{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:26:35Z","timestamp":1788107195765,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background and objective<\/jats:title>\n Vitiligo is an acquired depigmentation disorder caused by melanocyte dysfunction or loss. Oxidative stress is widely considered a key driver to its pathogenesis. Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) is implicated in oxidative stress responses, although its role in vitiligo remains uncertain. This study intended to investigate whether epigenetic downregulation of MAPKAPK2 aggravates oxidative stress-induced damage in vitiligo melanocytes.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Human melanocyte lines (PIG1 and PIG3V) were used to model normal and vitiligo conditions. The effects of oxidative stress, DNA demethylation (5-aza-DC), and MAPKAPK2 overexpression were assessed using qRT-PCR, Western blot, ELISA, comet assay, TUNEL, and CCK-8. Pharmacological inhibition of MK2 was employed to evaluate the functional requirement of MAPKAPK2 kinase activity, and key antioxidant pathways, including Nrf2 signaling, were investigated.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n MAPKAPK2 expression was notably downregulated in PIG3V cells compared with PIG1 cells (\n P<\/jats:italic>\n &lt;\n 0.05<\/jats:italic>\n ), and further reduced upon H\n 2<\/jats:sub>\n O\n 2<\/jats:sub>\n exposure (\n P<\/jats:italic>\n &lt;\n 0.01<\/jats:italic>\n ), suggesting stress-related suppression. Exposure to 5-aza-DC partially restored MAPKAPK2 expression (\n P<\/jats:italic>\n &lt;\n 0.01<\/jats:italic>\n ), implicating DNA methylation in its silencing. Functional assays showed that MAPKAPK2 overexpression significantly alleviated H\n 2<\/jats:sub>\n O\n 2<\/jats:sub>\n -induced reductions in cell viability, increases in apoptosis, impaired melanogenesis, and oxidative damage (all\n P<\/jats:italic>\n &lt;\n 0.01<\/jats:italic>\n ), while activating the Nrf2\/HO-1 antioxidant pathway through suppression of KEAP1 expression and enhancement of Nrf2 nuclear translocation. Genetic knockdown, rescue, and pharmacological inhibition experiments further demonstrated that these cytoprotective effects under oxidative stress were dependent on MAPKAPK2 kinase activity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Epigenetic silencing of MAPKAPK2 aggravates oxidative damage in vitiligo melanocytes, potentially by attenuating Nrf2-associated antioxidant responses. These findings identify MAPKAPK2 as a functionally relevant and targetable factor in the oxidative pathology of vitiligo.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2026.1698091","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:35Z","timestamp":1776658415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigenetic downregulation of MAPKAPK2 exacerbates oxidative stress-induced damage in vitiligo melanocyte cell line model"],"prefix":"10.3389","volume":"13","author":[{"given":"Yishan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","article-title":"Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo","volume":"61","author":"Wang","year":"2021","journal-title":"Clin Rev Allergy Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/bjd\/ljae282","article-title":"The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study","volume":"192","author":"Eleftheriadou","year":"2025","journal-title":"Br J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.12659\/MSM.914898","article-title":"Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"},{"key":"B4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J Dermatol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"14951","DOI":"10.1002\/jcp.28334","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","volume":"234","author":"Rezatabar","year":"2019","journal-title":"J cell physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-12-6","article-title":"A p38MAPK\/MK2 signaling pathway leading to redox stress, cell death and ischemia\/reperfusion injury","volume":"12","author":"Ashraf","year":"2014","journal-title":"Cell Commun Signal"},{"key":"B10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/ijms23010370","article-title":"The p38 MAPK components and modulators as biomarkers and molecular targets in cancer","volume":"23","author":"Garc\u00eda-Hern\u00e1ndez","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mrgentox.2018.05.018","article-title":"The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response","volume":"836","author":"Roy","year":"2018","journal-title":"Mut Res Genet Toxicolo Environ Mutagen."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12641","DOI":"10.3390\/ijms222312641","article-title":"Ra\u010dkov\u00e1, Skin Aging, Cellular Senescence and Natural Polyphenols","volume":"22","author":"Csekes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00403-019-02005-9","article-title":"DNA methylation and inflammatory skin diseases","volume":"312","author":"Mervis","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.3390\/ijms24054666","article-title":"Role of plant-derived compounds in the molecular pathways related to inflammation","volume":"24","author":"Oledzka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fphar.2020.00536","article-title":"Paeoniflorin resists H(2)O(2)-induced oxidative stress in melanocytes by JNK\/Nrf2\/HO-1 pathway","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2018.10.421","article-title":"Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway","volume":"129","author":"Ma","year":"2018","journal-title":"Free Radic Biol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jdermsci.2024.02.009","article-title":"Oxidative stress-induced hypermethylation and low expression of ANXA2R: novel insights into the dysfunction of melanocytes in vitiligo","volume":"114","author":"Chen","year":"2024","journal-title":"J Dermatol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/exd.14334","article-title":"Epigenetic-modifying therapies: an emerging avenue for the treatment of inflammatory skin diseases","volume":"30","author":"Yi","year":"2021","journal-title":"Exp Dermatol"},{"key":"B20","doi-asserted-by":"publisher","author":"Teli","year":"2024","DOI":"10.1201\/9781351058032-4"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/hex.13568","article-title":"Patient perspectives on primary care for multimorbidity: an integrative review","volume":"25","author":"Moody","year":"2022","journal-title":"Health Expect"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.18240\/ijo.2021.08.19","article-title":"Therapeutic effect of Keap1-Nrf2-ARE pathway-related drugs on age-related eye diseases through anti-oxidative stress","volume":"14","author":"Cai","year":"2021","journal-title":"Int J Ophthalmol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40291-023-00672-z","article-title":"Oxidative stress and potential antioxidant therapies in vitiligo: a narrative review","volume":"27","author":"Bia\u0142czyk","year":"2023","journal-title":"Mol Diagn Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2: INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","article-title":"The cytoprotective role of the Keap1\u2013Nrf2 pathway","volume":"85","author":"Baird","year":"2011","journal-title":"Arch Toxicol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1698091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:36Z","timestamp":1776658416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1698091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":25,"alternative-id":["10.3389\/fmed.2026.1698091"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1698091","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1698091"}}